MD2551G2 - Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses - Google Patents

Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses

Info

Publication number
MD2551G2
MD2551G2 MDA20030280A MD20030280A MD2551G2 MD 2551 G2 MD2551 G2 MD 2551G2 MD A20030280 A MDA20030280 A MD A20030280A MD 20030280 A MD20030280 A MD 20030280A MD 2551 G2 MD2551 G2 MD 2551G2
Authority
MD
Moldova
Prior art keywords
mycoses
treatment
pharmaceutically acceptable
oral cavity
ozonized
Prior art date
Application number
MDA20030280A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Андрей ПЫРГАРЬ
Борис ПЫРГАРЬ
Original Assignee
Андрей ПЫРГАРЬ
Борис ПЫРГАРЬ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Андрей ПЫРГАРЬ, Борис ПЫРГАРЬ filed Critical Андрей ПЫРГАРЬ
Priority to MDA20030280A priority Critical patent/MD2551G2/en
Publication of MD2551G2 publication Critical patent/MD2551G2/en

Links

Abstract

The invention refers to medicine, in particular to stomatology.Summary of the invention consists in using pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses.
MDA20030280A 2003-12-03 2003-12-03 Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses MD2551G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20030280A MD2551G2 (en) 2003-12-03 2003-12-03 Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20030280A MD2551G2 (en) 2003-12-03 2003-12-03 Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses

Publications (1)

Publication Number Publication Date
MD2551G2 true MD2551G2 (en) 2005-03-31

Family

ID=62129620

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20030280A MD2551G2 (en) 2003-12-03 2003-12-03 Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses

Country Status (1)

Country Link
MD (1) MD2551G2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2123319C1 (en) * 1996-12-24 1998-12-20 Нижегородская государственная медицинская академия Method of treating inflammatory diseases of parodontium
MD2354F1 (en) * 2003-07-29 2004-01-31 Boris Pirgari Method of treatment of the hepatic encephalopathy
MD2375F1 (en) * 2003-07-29 2004-02-29 Constantin Tibirna Method of portal gastropathy treatment in hepatic cirrhosis
MD2327G2 (en) * 2003-07-11 2004-07-31 Андрей ПЫРГАРЬ Method of treatment of parodontium affections

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2123319C1 (en) * 1996-12-24 1998-12-20 Нижегородская государственная медицинская академия Method of treating inflammatory diseases of parodontium
MD2327G2 (en) * 2003-07-11 2004-07-31 Андрей ПЫРГАРЬ Method of treatment of parodontium affections
MD2354F1 (en) * 2003-07-29 2004-01-31 Boris Pirgari Method of treatment of the hepatic encephalopathy
MD2375F1 (en) * 2003-07-29 2004-02-29 Constantin Tibirna Method of portal gastropathy treatment in hepatic cirrhosis

Similar Documents

Publication Publication Date Title
YU30004A (en) Use of flibanserin in the treatment of sexual disorders
IL176452A0 (en) Effervescent oral opiate dosage form
TW200505881A (en) Tri(cyclo) substituted amide compounds
TW200500358A (en) Compounds
IL171974A0 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
PL1654253T3 (en) Substituted 3-pyrrolidin-indole derivatives
EA200702522A1 (en) SYSTEM OF DELIVERY OF MEDICINES IN THE CAVITY OF THE MOUTH AND METHODS OF ITS APPLICATION
TW200716204A (en) Pharmaceutical composition
HRP20041092A2 (en) New pharmaceutical compositions containing filbanserin polymorph a
IL166337A0 (en) Oral administration of calctionin
WO2002088100A3 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
IL175303A0 (en) Oral formulations for 5-ht-receptor agonists, uses and methods of treatment employing the same
WO2005082413A3 (en) Ciclesonide and glycopyrronium combination
GR1004358B (en) Anhydrous crystalline valaciclivier hydrochloride
UA83821C2 (en) Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain
UA85685C2 (en) Use of quinolone antibiotics for controlling bacterial diseases of oral cavity
RS20050835A (en) Compositions of buccal dosage forms for extended drug release and the process of preparing such compositions
MX260260B (en) Semi-solid formulations for the oral administration of taxoids.
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
EG24959A (en) Indoles useful in the treatment of androgenreceptor related diseases.
MD2551G2 (en) Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses
MXPA05007253A (en) Novel anticonvulsant derivative salts.
SI1474415T1 (en) 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases
UA90843C2 (en) Tri(cyclo) substituted amide compounds
GB0128071D0 (en) Medicament

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees